Effectiveness of antimicrobial hospital curtains on reducing bacterial contamination—A multicenter study

Objective To determine the efficacy of 2 types of antimicrobial privacy curtains in clinical settings and the costs involved in replacing standard curtains with antimicrobial curtains. Design A prospective, open-labeled, multicenter study with a follow-up duration of 6 months. Setting This study included 12 rooms of patients with multidrug-resistant organisms (MDROs) (668 patient bed days) and 10 cubicles (8,839 patient bed days) in the medical, surgical, neurosurgical, orthopedics, and rehabilitation units of 10 hospitals. Method Culture samples were collected from curtain surfaces twice a week for 2 weeks, followed by weekly intervals. Results With a median hanging time of 173 days, antimicrobial curtain B (quaternary ammonium chlorides [QAC] plus polyorganosiloxane) was highly effective in reducing the bioburden (colony-forming units/100 cm 2 , 1 vs 57; P Staphylococcus aureus , 0.5% vs 24% ( P Acinetobacter spp, 0.2% vs 22.1% ( P Acinetobacter spp, 0% vs 13.2% ( P P = .001). Conclusions Antimicrobial curtain B (QAC plus polyorganosiloxane) but not antimicrobial curtain A (built-in silver) effectively reduced the microbial burden and MDRO contamination compared with the standard curtain, even after extended use in an active clinical setting. The antimicrobial curtain provided an opportunity to avert indirect costs related to curtain changing and laundering in addition to improving patient safety.